Guangzhou Trauer Biotechnology Co., Ltd.
标题
标题
Home
>
News
>
Company News
>
Good News | Trauer Biotech. Completed FDA MAF Filing, Making Another Step to Globalization
Good News | Trauer Biotech. Completed FDA MAF Filing, Making Another Step to Globalization
Prev:
As a Leading China Medical Collagen Raw Material Supplier, Trauer Biotech Presents Triple-Helix Atelocollagen Mechanisms for Skin Repair at Prestigious GRC Conference
Next:
Trauer Biotechnology's porcine type I atelocollagen raw material completes the registration of the NMPA medical device raw material master file!
